Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI

被引:71
作者
Abdullah, Siraj Saadaldin [2 ,3 ]
Pialat, Jean Baptiste [1 ,3 ]
Wiart, Marlene [3 ]
Duboeuf, Francois [3 ]
Mabrut, Jean-Yves [2 ]
Bancel, Brigitte [4 ]
Rode, Agnes [1 ]
Ducerf, Christian [2 ]
Baulieux, Jacques [2 ]
Berthezene, Yves [1 ,3 ]
机构
[1] La Croix Rousse Teaching Hosp, Dept Radiol, F-69317 Lyon 04, France
[2] La Croix Rousse Teaching Hosp, Dept Gen Surg & Liver Transplantat, F-69317 Lyon 04, France
[3] Univ Lyon, Creatis, INSERM,U630, CNRS,UMR 5220,INSA Lyon, Lyon, France
[4] La Croix Rousse Teaching Hosp, Dept Histopathol, F-69317 Lyon 04, France
关键词
liver; quantification; MRI; cancer; microvascular;
D O I
10.1002/jmri.21429
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
Purpose: To characterize and compare hepatocellular carcinoma and liver metastases of colorectal metastatic cancer (CMC) by means of quantitative liver perfusion MRI. Materials and Methods: Liver perfusion was assessed in 26 HCC and CMC patients (50 nodules) by means of contrast-enhanced MRI. Six perfusion parameters-hepatic perfusion index (HPn, mean transit time (MTh, distribution volume (DlI, total blood flow (FT), arterial blood flow (FA), and portal blood flow (Fp)-were calculated in tumor nodules and the adjacent hepatic parenchyma. Results: The values of FT, FA, Fp, and DV were significantly higher in the HCC than in the CMC group, whereas MTT was significantly higher in the CMC group. There was no significant difference in HPI. Arterial blood flow was higher than portal blood flow in the CMC group, while portal blood flow was slightly higher than arterial blood flow in the HCC group. Conclusion: The present work describes the use of dynamic MRI to quantitatively assess liver perfusion, which in the future may help studying liver cancers on the basis of their microvascular characteristics.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 36 条
[1]
Hepatic flow parameters measured with MR imaging and Doppler US: Correlations with degree of cirrhosis and portal hypertension [J].
Annet, L ;
Materne, R ;
Danse, E ;
Jamart, J ;
Horsmans, Y ;
Van Beers, BE .
RADIOLOGY, 2003, 229 (02) :409-414
[2]
Treatment of hepatic metastases from colorectal cancer: Many doubts, some certainties [J].
Biasco, G. ;
Derenzini, E. ;
Grazi, GL. ;
Ercolani, G. ;
Ravaioli, M. ;
Pantaleo, M. A. ;
Brandi, G. .
CANCER TREATMENT REVIEWS, 2006, 32 (03) :214-228
[3]
A PROSPECTIVE RANDOMIZED TRIAL OF REGIONAL VERSUS SYSTEMIC CONTINUOUS 5-FLUORODEOXYURIDINE CHEMOTHERAPY IN THE TREATMENT OF COLORECTAL LIVER METASTASES [J].
CHANG, AE ;
SCHNEIDER, PD ;
SUGARBAKER, PH ;
SIMPSON, C ;
CULNANE, M ;
STEINBERG, SM .
ANNALS OF SURGERY, 1987, 206 (06) :685-693
[4]
Early changes in liver perfusion caused by occult metastases in rats:: Detection with quantitative CT [J].
Cuenod, CA ;
Leconte, I ;
Siauve, N ;
Resten, A ;
Dromain, C ;
Poulet, B ;
Frouin, F ;
Clément, O ;
Frija, G .
RADIOLOGY, 2001, 218 (02) :556-561
[5]
Surgical treatment of malignant liver tumours [J].
DeMatteo, RP ;
Fong, YM ;
Blumgart, LH .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 1999, 13 (04) :557-574
[6]
Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives [J].
Eichhorn, ME ;
Strieth, S ;
Dellian, M .
DRUG RESISTANCE UPDATES, 2004, 7 (02) :125-138
[7]
Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent [J].
Fournier, LS ;
Cuenod, CA ;
de Bazelaire, C ;
Siauve, N ;
Rosty, C ;
Tran, PL ;
Frija, G ;
Clement, O .
EUROPEAN RADIOLOGY, 2004, 14 (11) :2125-2133
[8]
Gharbi Lassad, 2006, Tunis Med, V84, P683
[9]
HEPATIC VASCULAR BED [J].
GREENWAY, CV ;
STARK, RD .
PHYSIOLOGICAL REVIEWS, 1971, 51 (01) :23-+
[10]
CT perfusion at early stage of hepatic diffuse disease [J].
Guan, Sheng ;
Zhao, Wei-Dong ;
Zhou, Kang-Rong ;
Peng, Wei-Jun ;
Mao, Jian ;
Tang, Feng .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (22) :3465-3467